Market Overview:
The global nitinol-based stent market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of cardiovascular diseases, technological advancements in stent design and development, and rising demand for minimally invasive procedures. Based on type, the global nitinol-based stent market is segmented into bare-metal stents (BMS) and drug-eluting stents (DES). The BMS segment is expected to account for a larger share of the global nitinol-based stent market than the DES segment during the forecast period. This can be attributed to factors such as lower cost and shorter treatment time associated with BMS compared with DES. However, DES are increasingly being used owing to their superior efficacy in preventing restenosis as compared with BMS. Based on application, the global nitinol-based stent market is divided into hospital settings, clinics settings, and other applications such as research laboratories and veterinary clinics.
Product Definition:
A Nitinol-based stent is a medical device that is implanted in the body to hold open an artery and improve blood flow. The device is made from a nickel-titanium alloy that can be compressed into a small diameter for delivery and then expands to its original size when it reaches the target area.
Bare-metal Stent (BMS):
Bare-metal stent (BMS) is a type of stent used in the treatment of coronary artery disease. It is also used to treat blocked arteries, peripheral vascular disease and blood clots in lungs & legs.
Drug-eluting Stent (DES):
A drug-eluting stent is a medical device used to treat blocked or narrowing of a blood vessel. DES are made of materials that prevent the release of drugs by cancer cells, thereby, allowing them to act as a shield against the chemotherapy drugs. The DES are designed in such a way that they can degrade or wear off over time; however, it doesn’t affect the health of patients who have undergone treatment with this device.
Application Insights:
Nitinol-based stents are used in the treatment of various diseases such as coronary artery disease, peripheral vascular disease, and cerebrovascular disorders. In 2017, coronary artery diseases accounted for the largest market share owing to a high incidence rate of heart-related deaths coupled with rising awareness about early diagnosis and treatment. According to data published by WHO in 2018, out of 17 million premature deaths globally every year due to CVDs only 35% occur in developed countries while 65% occur in developing countries. This factor is anticipated to fuel demand from emerging economies over the forecast period.
Nitinol-based stents are majorly used for treating arteries that have been affected by atherosclerosis which is a chronic condition where plaque buildups along with fatty acids & cholesterol deposits inside blood vessels narrows or blocks blood flow through these vessels resulting in chest pain (angina) or shortness of breath (dyspnea).
Regional Analysis:
North America dominated the global nitinol-based stent market in 2016 with a revenue share of over 35%. The growth can be attributed to factors such as increasing incidence of coronary heart diseases, growing geriatric population, and rising healthcare expenditure. Moreover, technological advancements coupled with high R&D investment by government organizations are also expected to drive the market growth during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to factors such as improving economic conditions and rapid development in key economies such as India and China. In addition, favorable government initiatives for cardiovascular disease prevention are also expected boost product demand during the projected time frame. Furthermore, increasing medical tourism due to affordable treatment options is further anticipated propel regional market expansion.
Growth Factors:
- Increasing incidence of cardiovascular diseases (CVDs) due to changing lifestyles and aging population.
- Growing demand for minimally invasive procedures and technological advancements in stent devices.
- Rising healthcare expenditure and increasing awareness about the benefits of nitinol-based stents among patients and physicians.
- Stringent regulatory approvals for novel medical devices and reimbursement policies by government bodies worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Nitinol-based Stent Market Research Report
By Type
Bare-metal Stent (BMS), Drug-eluting Stent (DES)
By Application
Hospital, Clinics, Other
By Companies
Medtronic, Edwards Lifesciences, Abbott, Boston Scientific, TERUMO, C. R. Bard, Cordis, Cook Medical, B. Braun, Biotronik, Stryker, JOTEC, MicroPort, Acandis, ELLA-CS
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
157
Number of Tables & Figures
110
Customization Available
Yes, the report can be customized as per your need.
Global Nitinol-based Stent Market Report Segments:
The global Nitinol-based Stent market is segmented on the basis of:
Types
Bare-metal Stent (BMS), Drug-eluting Stent (DES)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinics, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic
- Edwards Lifesciences
- Abbott
- Boston Scientific
- TERUMO
- C. R. Bard
- Cordis
- Cook Medical
- B. Braun
- Biotronik
- Stryker
- JOTEC
- MicroPort
- Acandis
- ELLA-CS
Highlights of The Nitinol-based Stent Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Bare-metal Stent (BMS)
- Drug-eluting Stent (DES)
- By Application:
- Hospital
- Clinics
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Nitinol-based Stent Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Nitinol-based stents are a type of medical device that is made from nitinol, which is a metal alloy that has been treated with a strong acid. Nitinol-based stents are used to prop open arteries in the heart and other areas of the body.
Some of the major companies in the nitinol-based stent market are Medtronic, Edwards Lifesciences, Abbott, Boston Scientific, TERUMO, C. R. Bard, Cordis, Cook Medical, B. Braun, Biotronik, Stryker, JOTEC, MicroPort, Acandis, ELLA-CS.
The nitinol-based stent market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Nitinol-based Stent Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Nitinol-based Stent Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Nitinol-based Stent Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Nitinol-based Stent Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Nitinol-based Stent Market Size & Forecast, 2020-2028
4.5.1 Nitinol-based Stent Market Size and Y-o-Y Growth
4.5.2 Nitinol-based Stent Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Bare-metal Stent (BMS)
5.2.2 Drug-eluting Stent (DES)
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinics
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Nitinol-based Stent Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Nitinol-based Stent Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Bare-metal Stent (BMS)
9.6.2 Drug-eluting Stent (DES)
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinics
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Bare-metal Stent (BMS)
10.6.2 Drug-eluting Stent (DES)
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinics
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Bare-metal Stent (BMS)
11.6.2 Drug-eluting Stent (DES)
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinics
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Bare-metal Stent (BMS)
12.6.2 Drug-eluting Stent (DES)
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinics
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Bare-metal Stent (BMS)
13.6.2 Drug-eluting Stent (DES)
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinics
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Nitinol-based Stent Market: Competitive Dashboard
14.2 Global Nitinol-based Stent Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Medtronic
14.3.2 Edwards Lifesciences
14.3.3 Abbott
14.3.4 Boston Scientific
14.3.5 TERUMO
14.3.6 C. R. Bard
14.3.7 Cordis
14.3.8 Cook Medical
14.3.9 B. Braun
14.3.10 Biotronik
14.3.11 Stryker
14.3.12 JOTEC
14.3.13 MicroPort
14.3.14 Acandis
14.3.15 ELLA-CS
